Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $40 | In Stock | |
5 mg | $92 | In Stock | |
10 mg | $148 | In Stock | |
25 mg | $283 | In Stock | |
50 mg | $446 | In Stock | |
100 mg | $645 | In Stock | |
1 mL x 10 mM (in DMSO) | $98 | In Stock |
Description | Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy. |
Targets&IC50 | NNRT:119 nM (IC50) |
Alias | UK-453061, Lersivirine(UK 453061) |
Molecular Weight | 310.35 |
Formula | C17H18N4O2 |
Cas No. | 473921-12-9 |
Smiles | CCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N |
Relative Density. | 1.19 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (161.11 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.